Search: onr:"swepub:oai:DiVA.org:uu-175759" >
Immune Response Is ...
Immune Response Is an Important Aspect of the Antitumor Effect Produced by a CD40L-Encoding Oncolytic Adenovirus
-
- Diaconu, Iulia (author)
- University of Helsinki
-
- Cerullo, Vincenzo (author)
- University of Helsinki
-
- Hirvinen, Mari L M (author)
- University of Helsinki
-
show more...
-
- Escutenaire, Sophie (author)
- University of Helsinki
-
- Ugolini, Matteo (author)
- University of Helsinki
-
- Pesonen, Saila K (author)
- University of Helsinki
-
- Bramante, Simona (author)
- University of Helsinki
-
- Parviainen, Suvi (author)
- University of Helsinki
-
- Kanerva, Anna (author)
- University of Helsinki
-
- Loskog, Angelica S I (author)
- Uppsala universitet,Klinisk immunologi
-
- Eliopoulos, Aristides G (author)
- Hellas FORTH
-
- Pesonen, Sari (author)
- University of Helsinki
-
- Hemminki, Akseli (author)
- University of Helsinki
-
show less...
-
(creator_code:org_t)
- 2012
- 2012
- English.
-
In: Cancer Research. - 0008-5472 .- 1538-7445. ; 72:9, s. 2327-2338
- Related links:
-
https://urn.kb.se/re...
-
show more...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- Oncolytic adenovirus is an attractive platform for immunotherapy because virus replication is highly immunogenic and not subject to tolerance. Although oncolysis releases tumor epitopes and provides costimulatory danger signals, arming the virus with immunostimulatory molecules can further improve efficacy. CD40 ligand (CD40L, CD154) induces apoptosis of tumor cells and triggers several immune mechanisms, including a T-helper type 1 (TH1) response, which leads to activation of cytotoxic T cells and reduction of immunosuppression. In this study, we constructed a novel oncolytic adenovirus, Ad5/3-hTERT-E1A-hCD40L, which features a chimeric Ad5/3 capsid for enhanced tumor transduction, a human telomerase reverse transcriptase (hTERT) promoter for tumor selectivity, and human CD40L for increased efficacy. Ad5/3-hTERT-E1A-hCD40L significantly inhibited tumor growth in vivo via oncolytic and apoptotic effects, and (Ad5/3-hTERT-E1A-hCD40L)–mediated oncolysis resulted in enhanced calreticulin exposure and HMGB1 and ATP release, which were suggestive of immunogenicity. In two syngeneic mouse models, murine CD40L induced recruitment and activation of antigen-presenting cells, leading to increased interleukin-12 production in splenocytes. This effect was associated with induction of the TH1 cytokines IFN-γ, RANTES, and TNF-α. Tumors treated with Ad5/3-CMV-mCD40L also displayed an enhanced presence of macrophages and cytotoxic CD8+ T cells but not B cells. Together, our findings show that adenoviruses coding for CD40L mediate multiple antitumor effects including oncolysis, apoptosis, induction of T-cell responses, and upregulation of TH1 cytokines.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database
- By the author/editor
-
Diaconu, Iulia
-
Cerullo, Vincenz ...
-
Hirvinen, Mari L ...
-
Escutenaire, Sop ...
-
Ugolini, Matteo
-
Pesonen, Saila K
-
show more...
-
Bramante, Simona
-
Parviainen, Suvi
-
Kanerva, Anna
-
Loskog, Angelica ...
-
Eliopoulos, Aris ...
-
Pesonen, Sari
-
Hemminki, Akseli
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Cancer and Oncol ...
- Articles in the publication
-
Cancer Research
- By the university
-
Uppsala University